drugset / Trial / NCT07075718
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
RandomizedSequentialTriple-blindTreatment
Summary
Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Timeline
- Start
- 2025-06-12
- Primary completion
- 2028-03
- Completion
- 2032-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Timolol | Other / unclassified | 0.5 % | Topical |
| Subject | Travoprost | Other / unclassified | — | Other |